These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18468892)
1. Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker. Satyam A Bioorg Med Chem Lett; 2008 Jun; 18(11):3196-9. PubMed ID: 18468892 [TBL] [Abstract][Full Text] [Related]
2. An assembly concept for the consecutive introduction of unsymmetrical disulfide bonds: synthesis of a releasable multidrug conjugate of folic acid. Vlahov IR; Santhapuram HK; Wang Y; Kleindl PJ; You F; Howard SJ; Westrick E; Reddy JA; Leamon CP J Org Chem; 2007 Aug; 72(16):5968-72. PubMed ID: 17602528 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates. Yang J; Chen H; Vlahov IR; Cheng JX; Low PS J Pharmacol Exp Ther; 2007 May; 321(2):462-8. PubMed ID: 17289839 [TBL] [Abstract][Full Text] [Related]
4. Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide. Vlahov IR; Santhapuram HK; Kleindl PJ; Howard SJ; Stanford KM; Leamon CP Bioorg Med Chem Lett; 2006 Oct; 16(19):5093-6. PubMed ID: 16870437 [TBL] [Abstract][Full Text] [Related]
5. Folate-mediated targeting of therapeutic and imaging agents to cancers. Reddy JA; Low PS Crit Rev Ther Drug Carrier Syst; 1998; 15(6):587-627. PubMed ID: 9883391 [TBL] [Abstract][Full Text] [Related]
6. Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part II: Folic acid conjugates of tubulysins and their hydrazides. Vlahov IR; Wang Y; Kleindl PJ; Leamon CP Bioorg Med Chem Lett; 2008 Aug; 18(16):4558-61. PubMed ID: 18657420 [TBL] [Abstract][Full Text] [Related]
7. Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acid. Vlahov IR; Vite GD; Kleindl PJ; Wang Y; Santhapuram HK; You F; Howard SJ; Kim SH; Lee FF; Leamon CP Bioorg Med Chem Lett; 2010 Aug; 20(15):4578-81. PubMed ID: 20594844 [TBL] [Abstract][Full Text] [Related]
8. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads. Ojima I Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and activity of a folate peptide camptothecin prodrug. Henne WA; Doorneweerd DD; Hilgenbrink AR; Kularatne SA; Low PS Bioorg Med Chem Lett; 2006 Oct; 16(20):5350-5. PubMed ID: 16901694 [TBL] [Abstract][Full Text] [Related]
11. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates. Reddy JA; Westrick E; Vlahov I; Howard SJ; Santhapuram HK; Leamon CP Cancer Chemother Pharmacol; 2006 Aug; 58(2):229-36. PubMed ID: 16331500 [TBL] [Abstract][Full Text] [Related]
12. Mutual prodrugs containing bio-cleavable and drug releasable disulfide linkers. Jain AK; Gund MG; Desai DC; Borhade N; Senthilkumar SP; Dhiman M; Mangu NK; Mali SV; Dubash NP; Halder S; Satyam A Bioorg Chem; 2013 Aug; 49():40-8. PubMed ID: 23886697 [TBL] [Abstract][Full Text] [Related]
13. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys. Yang JJ; Kularatne SA; Chen X; Low PS; Wang E Mol Pharm; 2012 Feb; 9(2):310-7. PubMed ID: 22171616 [TBL] [Abstract][Full Text] [Related]
14. in vitro biological evaluation of folate-functionalized block copolymer micelles for selective anti-cancer drug delivery. Licciardi M; Craparo EF; Giammona G; Armes SP; Tang Y; Lewis AL Macromol Biosci; 2008 Jul; 8(7):615-26. PubMed ID: 18432597 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological activity of folate receptor-targeted prodrugs of thiolate histone deacetylase inhibitors. Suzuki T; Hisakawa S; Itoh Y; Suzuki N; Takahashi K; Kawahata M; Yamaguchi K; Nakagawa H; Miyata N Bioorg Med Chem Lett; 2007 Aug; 17(15):4208-12. PubMed ID: 17532630 [TBL] [Abstract][Full Text] [Related]
16. Melanoma-targeted delivery system (part 1): design, synthesis and evaluation of releasable disulfide drug by glutathione. El Aissi R; Chezal JM; Tarrit S; Chavignon O; Moreau E Eur J Med Chem; 2015 Aug; 101():668-80. PubMed ID: 26210505 [TBL] [Abstract][Full Text] [Related]
17. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777 [TBL] [Abstract][Full Text] [Related]
18. Polymer therapeutics: concepts and applications. Haag R; Kratz F Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775 [TBL] [Abstract][Full Text] [Related]
19. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters. Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781 [TBL] [Abstract][Full Text] [Related]
20. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV Biomaterials; 2007 Jan; 28(3):504-12. PubMed ID: 16996126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]